GlobeNewsWire
14 Oct 2026, 18:40 UTC · 1h ago
Impact · against what's priced in
The announcement of a lead plaintiff deadline for an existing securities fraud lawsuit is a procedural update with negligible impact. It does not change the fundamental risk profile of the company's legal liabilities.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
A securities fraud class action lawsuit is ongoing against Unicycive Therapeutics (UNCY) for purchases made between December 29, 2025, and June 29, 2026.
Priced inreminder of an existing lawsuit
More negative than 77% of claims this week
The deadline to file a lead plaintiff motion for the UNCY class action is November 2, 2026.
New
Continue reading
5 related stories
The reminder of a November 2, 2026, deadline for lead plaintiff motions in a class action lawsuit serves as a procedural update to an ongoing legal risk.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 62% of claims this week
Which stocks this story touches
More negative than 85% of ticker scores this week
The company is the subject of a class action lawsuit filed on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
−0.8%
Price agrees with the score
$3.70 vs $3.73 close before publication (Oct 13) · not market-adjusted
UNCY chart →
